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Abstract 
Background:  
Food allergy can have a significant impact on health related quality of life (HRQoL). Parental proxy 
questionnaires are commonly used when children are too young to complete questionnaires 
themselves. Little data is available on HRQoL in children with non-IgE-mediated gastrointestinal food 
allergy (GIFA). The aim of this study was to evaluate HRQoL in these children by parent proxy.  
 
Methods: 
A cross-sectional questionnaire study was conducted with children 2-16 years old with confirmed (GIFA).  
Parents of these children completed the Paediatric Quality of Life Inventory (PedsQLTM) and the Family 
Impact module of the PedsQL. The PedsQL scores were compared to two published cohorts: functional 
abdominal pain (FAP) and IgE-mediated food allergy.  
 
Results: 
Fifty-two parents of children with GIFA completed the PedsQLTM parent proxy.  The GIFA cohort had 
significantly better overall HRQoL compared to the FAP cohort, but lower emotional functioning scores.  
The GIFA cohort also had poorer physical QoL compared to the IgE cohort (all p<0.05).  The more foods 
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excluded, comorbidity of nasal congestion, abdominal pain, back arching, the persistence of flatus and 
gastrointestinal symptom severity after elimination diet were related to poorer QoL in this non-IgE 
cohort.  Regression analyses showed that number of foods and nasal congestion significantly predicted 
total QoL score as perceived by parents. 
 
Conclusions: 
This study has shown that different areas of HRQoL of children with GIFA are affected compared to 
children with FAP or IgE-mediated food allergy, highlighting the need for a specific GIFA HRQoL 
questionnaire to better understand the impact on these children.  
 
Background 
The impact of ImmunoglobulinE (IgE)-mediated food allergy on children and their families, particularly 
for health-related quality of life (HRQoL), has been well-documented (1-3). Studies have shown that 
food allergies can cause significant psychological and emotional burden on children and their families 
compared to children without food allergy (1, 4). Valentine and Knibb for example showed that children 
with food allergies had difficulties with school lunches, experienced restrictions on favourite foods and 
carrying medication had a negative influence on HRQoL (5). Parents reported lower HRQoL with regards 
to shopping and concern over the health of their child compared to parents of children without food 
allergy (5).  
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Specific food allergic HRQoL questionnaires have now been validated for IgE-mediated food allergy. 
These comprise questions such as food anxiety, social and dietary eliminations and the emotional 
impact on parents and their children (8-10).   There is, however, a paucity of data assessing the impact 
on children’s HRQoL in non-IgE-mediated gastrointestinal food allergies (GIFA) (11, 12).  The European 
Academy of Allergy and Clinical Immunology have acknowledged that a validated tool to measure 
HRQoL in this group of children is required and the tools available for children with IgE-mediated food 
allergy are not suitable for those with GIFA (9).  
 
Studies using more generic HRQoL measures have been used. For example, Klinnert et al (13) looked at 
family HRQoL in children diagnosed with eosinophilic oesophagitis, a GIFA condition, using a generic 
paediatric quality of life questionnaire (PedsQL) and found that these children and their families 
reported a diminished HRQoL compared to healthy individuals, with lower scores in the children with 
increased severity of symptoms and number of foods eliminated (13). Meyer et al looked at the impact 
of GIFA on the family  (using the Family Impact Module PedsQLTM questionnaire) and showed that this 
was worse compared to families of children with chronic diseases such as sickle cell disease and 
intestinal failure (14).  
 
Children with GIFA are usually young and present with symptoms in infancy. Parental proxy 
questionnaires are commonly used when children are too young to complete questionnaires 
themselves. The aim of the present study was to better understand the HRQoL of children with GIFA 
through assessment by parental proxy and comparison with published data on HRQoL of children with 
IgE-mediated food allergy and children with functional abdominal pain (FAP) (15, 16) 
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Method 
Design 
A cross-sectional questionnaire study was carried out at Great Ormond Street Hospital, London, United 
Kingdom from December 2011 and November 2013. Ethical approval was granted for the study 
(NR11/LO/1177) and all parents gave written informed consent.   
 
Participants and Procedure 
Parents of children aged 2 to 16 years were approached to take part in the study where an elimination 
diet had improved a child’s symptoms of GIFA. This included children with eosinophilic gastrointestinal 
disorders, allergic dysmotility disorders and food protein-induced enterocolitis. Symptom improvement 
was established using a previously published questionnaire that ranked gastrointestinal symptoms 
according to a Likert scale (Appendix 1).  This questionnaire was initially completed in clinic at the start 
of the elimination diet (baseline) and then sent by post at 4 and 8 weeks during their elimination diet 
and completed via phone interview (17). Data on the assessment of symptom improvement has been 
published in further detail by Lozinsky et al (18).  Once symptom improvement was seen on the 
elimination diet, parents were sent the Pediatric Quality of Life Inventory (PedsQLTM) proxy 
questionnaire and the Family Impact Module (FIM) of the PedsQLTM (19) by post. A research 
appointment was scheduled for researchers to answer any questions about the questionnaire content. 
Subsequent home food introductions have occurred in all children but this work is yet to be published. 
Children with non-allergic co-morbidities and those who did not have any symptom improvement during 
the elimination diet period were excluded.  
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Materials  
The PedsQLTM has been validated for parental proxy use in children above 2 years of age (17). It is scored 
out of 100 and a higher score represents a better QoL. The Family Impact Module (FIM) PedsQLTM 
Questionnaire (19) assesses the impact on the HRQoL of the family as a whole (see Appendix 2 for full 
details of the scales used).  
 
Comparison Groups 
Our data was compared to three published control groups who had also used the Parental Proxy 
PedsQLTM tool to assess HRQoL. The first comparison was made with our cohort to published norm data 
for this scale (20). The other two groups were children with FAP (mean age = 11.2 years) (15) and those 
with IgE-mediated peanut allergy (mean age of children = 9.8 years; fathers mean age = 45.33, SD=4.42; 
mothers mean age = 42.59, SD=4.46) (16).  FAP was chosen as it is a gastrointestinal disorder which can 
present with similar symptoms to GIFA (i.e. abdominal pain) and both can take time to diagnose which is 
likely to have a significant impact on HRQoL. The IgE group was selected because of the similarities to 
GIFA, such as food avoidance, difficulties experienced in social situations involving food and anxiety 
around food exclusions, in spite of the more acute onset of peanut allergy. Comparisons with this group 
were conducted with non-IgE children aged 5-12 years only in order to ensure age groups of the two 
cohorts were comparable.  
Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 22 (Armonk, NY).  Data 
was checked for skew and kurtosis and was within acceptable levels for normal distribution.  One 
sample t-tests were run to look at differences between PedsQLTM scores for the GIFA group and norm 
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data.  Between-subject t-tests were used to compare PedsQL scores between children with GIFA and the 
cohorts of children with IgE-mediated food allergy and FAP. The study had 94% power to detect medium 
effect sizes for one sample t-tests, 50% power for comparisons with the IgE-mediated group and 75% for 
comparisons with the FAP group.  Pearson’s correlations were conducted to measure the relationship 
between Parent Proxy PedsQLTM scores and FIM PedsQLTM scores.  A multiple linear regression model 
was run to assess the relationship between PedsQLTM scores for parents of children with GIFA (outcome 
variable) and variables that were significantly associated with this measure.  All tests were two-sided 
and significance level was set to 0.05.  
 
Results 
A total of 66 children aged 2 to 16 years of age were identified with GIFA, of which 52 parents consented 
to participate and completed the PedsQLTM proxy questionnaire and the FIM.  The questionnaires were 
mainly completed by mothers (n=43, 82.7%), 3 (5.8%) by fathers and 6 (11.5%) did not specify which 
parent completed the questionnaire. Demographic data and GIFA characteristics of the children are 
described in Appendix 3. Over 50% of the patients had up to three foods eliminated and the most 
common combination of foods eliminated were cow’s milk, egg, soya and wheat (26.9%) or cow’s milk 
and soya (26.9%). Of the cohort, 61.5% had at least one comorbidity, with nasal congestion (67.3%) 
being the most prevalent.  
Comparisons between GIFA group PedsQL scores, FIM scores and norm data for the PedsQL 
The mean total parental proxy PedsQLTM score for the GIFA cohort was 75.43 (SD=13.82) with the lowest 
mean score seen in the domain of emotional functioning (mean=67.72, SD=19.58) (Table 1).  In 
comparison to norm data for the PedsQLTM, the GIFA cohort had significantly worse physical (t(25)=-
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2.36, p=.03), emotional (t(25)=-2.62, p=.02), psychosocial (t(25)=-2.20, p=.04) and total quality of life 
(t(25)=-2.12, p=.04) (Table 1).  Poorer parent rated HRQoL for the child was significantly related to 
poorer family related QoL (r=0.58, p<0.001).  
 
Comparisons between GIFA, IgE and FAP cohorts 
Overall HRQoL and social functioning QoL were significantly better in the GIFA cohort compared to the 
FAP cohort; however, the GIFA cohort had significantly worse HRQoL scores for emotional functioning 
(Table 2).  In comparison to the IgE cohort, there were no significant differences in overall HRQoL but 
the GIFA group had significantly poorer QoL for physical functioning (Table 3). 
 
Relationships between GIFA characteristics and quality of life 
Univariate analysis showed that the parental proxy total PedsQLTM scores for children with GIFA were 
significantly related to the number of foods excluded (r=-.38, p=0.006) and scores for gastrointestinal 
symptoms (r=-.32, p=0.021), abdominal pain (r=-.28, p=0.043), back arching (r=-.40, p=0.003) and flatus 
(r=-.28, p=0.047) after commencement of the elimination diet.  Children with nasal congestion had 
significantly poorer total QoL (n=35, mean=72.84, SD=14.96) compared to children with no nasal 
congestion (n=17, mean=80.75, SD=9.40), (t(46.47) =2.32, p=0.025).  
 
When examining relationships between GIFA characteristics and subscales of the PedsQL there were 
significant correlations between the number of foods excluded and social (r=-.39, p=.005), nursery 
related (n=16, r=-.74, p=.001) and psychosocial (r=-.33, p=.018) QoL.  Severity scores for gastrointestinal 
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symptoms after commencement of the elimination diet was significantly related to physical (r=-.44, 
p=.001) and psychosocial (r=-.28, p=.046) QoL.  Children with nasal congestion had significantly poorer 
psychosocial QoL (n=35, mean=72.07, SD=15.30) compared to children without (n=17, mean=80.75, 
SD=10.55), (t(43.85)=2.41, p=.020).  Nursery related QoL was also negatively correlated with the child’s 
age (n=16, r=-.60, p=.013). 
 
Multiple linear regression analysis was conducted with variables that were significantly associated with 
QoL. The model was significant (F(6,45)=3.37, p=0.008) and explained 31% of the variance (R2=.31; Adj 
R2=.22) in total PedsQLTM HRQoL scores.  Factors that had a significant negative impact on the PedsQLTM 
total scores were the number of foods excluded and nasal congestion (Table 4). 
 
Discussion 
This study set out to understand the impact of GIFA on the HRQoL of children as reported by the 
parents. When compared to the norm data, our cohort had significantly worse total HRQoL scores 
especially in the physical, emotional and psychosocial functioning domains.  
 
When the GIFA children were compared to the IgE-mediated cohort, there were no significant 
differences in overall HRQoL; however, our cohort had poorer physical QoL. This may be due to the 
gastrointestinal symptoms that accompany GIFA including extra-manifestations such as pain, 
hypermobility and fatigue (21), which can significantly impair QoL that are not common in nut allergies.  
In our univariate analysis, persistent flatus following an elimination diet was significantly related to 
quality of life in our cohort, although this association disappeared in the regression analysis possibly due 
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to this variable being unable to explain any more variance in QoL over and above that of the number of 
foods and nasal congestion.  Lozinsky et al (18) found that 26% of participants had flatus as a symptom 
on dietary elimination. It therefore seems a persistent symptom that could affect quality of life through 
discomfort, pain and poor sleep (18). There is paucity of data on the impact of flatus on HRQoL in GIFA 
although in our experience parents reported night waking was common with painful passage of flatus. In 
an adult study where 71% had flatulence, the presence of gastrointestinal symptoms was reported to 
have a negative impact on HRQoL (22). In a study by Abaci et al., mothers of infants with infantile colic 
defined as unexplained, inconsolable crying often accompanied with flushing of the face, drawing-up of 
the legs and passing of gas, reported poorer HRQoL especially in the domains of physical and social 
functioning (23). Our results also showed a significant negative impact on physical functioning in 
association with the severity of gastrointestinal symptoms (i.e. abdominal pain, back arching, flatus) 
post elimination diet.  
 
Emotional functioning was reported as the domain of HRQoL that parents felt their children with GIFA 
were most affected by and scores were significantly poorer than norm population data and children 
with FAP. Although not previously described for GIFA, feelings of anxiety and worry in children with food 
allergy has been well documented, with several studies on children with IgE-mediated peanut allergy 
reporting lower emotional health scores compared to children without food allergy (1, 16, 24). Poorer 
emotional HRQoL may be related to the children with GIFA experiencing emotional distress related to 
environments involving food or associating symptoms (i.e. abdominal pain, vomiting) with eating 
specific foods. Delays in diagnosis due to the absence of diagnostic tests for GIFA, which can lead to 
prolonged symptoms, may also have an impact on the emotional psychological health of children.   
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Emotional functioning can also be affected by quality of sleep or sleep deprivation (25). Previous studies 
with children affected by other atopic conditions (e.g. asthma, eczema) have shown that there is an 
increase in nocturnal awakening and disturbed sleep (26, 27). Poor sleep has been reported in 
approximately one third of patients with GIFA (21), which can impact their emotional health. Over half 
of our cohort had nasal congestion, which can be a manifestation of allergic rhinitis (28). This 
comorbidity may have an effect on sleep which could explain the lower scores we found in these 
children; however, this link requires further research.  
 
Eliminating multiple foods was found to have a negative correlation with HRQoL in our cohort, which 
has also been reported in children with IgE-mediated food allergy (2). It has been shown that anxiety 
increases in children if food elimination includes two or more foods (29) and this could have contributed 
to the poorer emotional HRQoL seen in our cohort.  
 
We found that poorer HRQoL in the child was related to a bigger impact on the whole family. This is a 
similar finding to that of Greenhawt et al (3030) where the HRQoL of carers of children with Food 
Protein-induced Enterocolitis Syndrome (FPIES), a type of GIFA, was compared to carers of children with 
IgE-mediated food allergies. Although they used a different questionnaire (Food Allergy Quality of Life – 
Parental Burden (FAQL-PB) Index), they found that carers of children with FPIES reported significantly 
worse QoL compared to those of children with IgE-mediated food allergy but also that the FAQL-PB 
scores correlated strongly with PedsQL-FIM scores.  
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Limitations 
This study had several limitations. Firstly, GIFA was diagnosed following symptom improvement after an 
elimination diet but was not confirmed with a follow up re-introduction challenge. Therefore, it is not a 
challenge-proven diagnosis. Secondly, the parent proxy PedsQLTM is designed to be used in children at 
least 2 years old.  In our cohort, there were a number of children who were less than 2 years old and as 
there was no tool available to assess their quality of life they were excluded. There was also no 
prospective control group available for us to compare our data to. Although the PedsQLTM is designed to 
be used for all types of diseases, it has not been specifically validated for parent proxy use for children 
with GIFA. GIFA can often start in infancy; thus developing a tool that allows for more specific GIFA 
disease-specific questions is important, but validating it for use by parents for younger children, unable 
to complete questionnaires themselves, is also necessary.  
 
Another limitation is that we used two historical comparison groups in our study where the children had 
different diseases and were recruited and interviewed by researchers differently. Although we tried to 
find cohorts that had some effects of quality of life that would be similar to children with GIFA, all 
chronic diseases have unique clinical features that can directly impact HRQoL and trying to make 
comparisons between diseases that are potentially different, can be challenging. We also had very few 
fathers take part in our study and future work should consider encouraging more fathers to give their 
views about the impact on quality of life.   
Due to the small sample sizes our study was underpowered to detect small effects and there may be 
more differences between these groups than we have been able to find.  In contrast to this, there is also 
the risk that we have made a Type I error and reported false positive differences due to the number of 
tests we ran.  As this is the first study to report on the impact of GIFA on QoL in comparison to other 
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similar chronic conditions, we felt it important to report all differences found so that future research can 
build upon these findings in robust and properly powered studies.  
 
Conclusions: 
This study has found that parent reported HRQoL of their children with GIFA was worse compared to a 
normal population. However, when compared to children with IgE-mediated allergy or FAP, only the 
domains of physical and emotional functioning, respectively, were significantly worse. The number of 
foods excluded, severity of gastrointestinal symptom scores and the presence of nasal congestion had a 
significant negative impact on total HRQoL score. Proxy parental HRQoL scores are useful; however, the 
development of a questionnaire that allows for specific assessment of children with GIFA of all ages is 
needed to better understand the impact of this disease on children’s lives.  
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Table 1: Proxy PedsQLTM scores of children with GIFA in different domains and norm data 
 Non-IgE cohort Norm data 
 N Mean SD Mean 
Nursery functioning (2-4 years) 16 72.40 19.65 N/A 
School functioning (≥5 years) 33 73.18 18.06 78.19 
Emotional functioning 51 67.72 19.58 81.04* 
Physical functioning 51 77.56 16.12 84.37* 
Social functioning 52 83.85 15.07 86.82 
Psychosocial functioning 52 74.94 14.43 82.11* 
Total Score 52 75.43 13.82 82.79* 
*p<0.05 
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Table 2:  Comparison of quality of life between the GIFA cohort and the FAP cohort 
 
§ - Assessment not performed in FAP by Youseef et al. (17) 
 
  
 Non-IgE-mediated cohort Functional Abdominal 
Pain Cohort 
Mean 
difference 
p-value 
 N Mean SD N Mean SD   
School (≥5 y) 33 73.18 18.06 65 72.2 15.80 -1.0 0.78 
Emotional 51 67.72 19.58 65 75.20 18.10 7.5 0.04 
Physical 51 77.56 16.12 65 76.94 11.80 -0.7 0.80
Social 52 83.85 15.07 65 67.10 12.30 -16.8 <0.001 
Psychosocial  52 74.94 14.43 65 § § § § 
Total average 52 75.43 13.82 65 70.10 7.90 -5.3 0.01 
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Table 3:  Comparison of quality of life between the GIFA cohort aged 5-12 years and the IgE cohort 
 
 
 
 Non-IgE-mediated 
cohort 
IgE-mediated 
cohort 
Mean 
difference 
p-value 
 N Mean SD n Mean SD  
Physical 26 77.37 15.08 44 89.92 11.41 12.55 <0.001 
Emotional 26 70.96 19.65 44 70.45 19.37 -.51 .92 
Social 27 82.96 15.83 44 81.93 15.67 -1.03 .79 
School (≥5 y) 27 72.78 18.83 44 77.50 19.30 4.72 .32 
Psychosocial  27 75.49 15.65 44 76.93 16.20 1.44 .72 
Total average 27 76.01 14.40 44 81.27 13.58 5.26 .13 
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Table 4.  Regression analysis to examine associations between non-IgE characteristics and total PedsQL 
scores. 
*p<.05, **p<.01 
 
 
Predictors Unstandardised 
Coefficients 
Standardised 
Coefficients 
95% Confidence 
intervals 
 B Standard 
Error 
Beta Lower Upper
Number of foods excluded -2.34 .90 -.33** -4.15 -.52
Gastrointestinal symptom .21 .55 .09 -.89 1.32 
Abdominal pain -3.42 4.41 -.12 -12.31 5.47 
Back arch -6.78 5.82 -.18 -18.50 4.93 
Flatus -6.00 5.12 -.22 -16.30 4.32
Nasal congestion -8.03 3.70 -.28* -15.49 -.57 
